Ask the Doctor: Hearing
03 March 2024

 

On the occasion of World Hearing Day, Nellie Mosesova, an audiologist at the "Arabkir" Medical Center, answered questions from news.am. She addressed topics such as how parents can identify hearing issues in newborns, the significance of newborn hearing screening, its implementation in Armenia and its outcomes, the causes of congenital and acquired hearing loss and deafness, available treatments for deafness, and whether screening and cochlear implants will eliminate the need for sign language.

How can parents recognize if their newborn child has hearing problems?
During a child’s early developmental stages, identifying hearing issues can be challenging. While there are specific developmental milestones, such as reaction to sounds, these may not always be evident. For example, a 1-month-old baby may not display a noticeable reaction to sound, except for perhaps focusing their gaze or a slight startle to loud, sharp noises. By around 3 months of age, babies begin to respond better to human voices, showing recognition of their mother’s voice and displaying excitement even without visual contact. Around 6 months, they start babbling and can clearly locate the source of sounds. By 1 year, we expect the child’s first words. While these milestones are important, instrumental examinations provide more accurate results. Hence, newborn hearing screening tests are conducted in maternity hospitals in Armenia during the first days of a child’s life. 

 

What is a newborn hearing screening test?
The newborn hearing screening test is a mass screening conducted in stages. The initial stage takes place in the maternity hospital during the first days of the newborn’s life, before discharge. If hearing loss is suspected, the test is repeated, with the second stage completed no later than 2 months of age. If doubts persist, a comprehensive audiologic examination is conducted, including more complex tests to diagnose any hearing loss and determine its severity.
 

Since when has screening been performed in Armenia and what are the outcomes? 

Newborn hearing screening in Armenia began in July 2008, initially in just 4 maternity hospitals. However, since 2018, nearly all maternity hospitals in Armenia have been equipped to perform this screening. The results align with international data, indicating that approximately one in a thousand children are born with hearing loss. 

 

What are the causes of congenital hearing loss and deafness?
Congenital hearing loss has various causes, often involving multiple factors. Genetics is the most common cause, accounting for 30-50% of cases. It's important to note that while labeled as hereditary, both parents may have normal hearing. Complications during pregnancy, particularly infections, are also significant contributors. Certain medications taken during pregnancy can lead to hearing loss. Additionally, premature or post-term (more than 42 weeks) births can increase the risk. Other contributing factors include maternal habits and comorbidities such as diabetes or anemia, which may affect fetal nutrition.


What are the causes of acquired hearing loss and deafness?
Acquired hearing loss often results from infectious diseases such as measles and COVID-19, as well as acute respiratory infections. Certain chemotherapeutic agents used in tuberculosis treatment can also lead to hearing loss. Additionally, traumatic brain injury and prolonged exposure to loud noise, often due to increased headphone use, are common causes.

 

What are the available treatment methods for hearing loss and deafness?
For acute hearing loss, timely treatment within the first 5 days is crucial, as interventions after 2 weeks are less effective. Therefore, seeking medical attention promptly is essential in cases of sudden hearing loss, as delays can be critical. Alternatively, if treatment is not possible, compensatory measures can be taken. Hearing aids are commonly used for this purpose, and if ineffective, surgical interventions such as cochlear implantation may be necessary.
 

Is it possible to achieve the level that there is no need for a special language for deaf and mute people?
Despite advancements in technology, including hearing aids and cochlear implants, there are still cases where these methods are ineffective, necessitating the use of sign language. However, with the rapid pace of technological development, there is hope that in the near future, both speech and hearing abilities can be significantly improved. 

Share on Facebook
Last news
Years of Tireless Work Recognized by the WHO
Years of Tireless Work Recognized by the WHO   The World Health Organization (WHO) has officially designated Arabkir Medical Center-Institute of Child and Adolescent Health (Arabkir MC-ICAH) as a “WHO Collaborating Centre” in the field of child and adolescent health. This recognition places Armenia among an elite group of nine countries in the WHO European Region, including Great Britain, France, Switzerland, Germany, Italy, Ireland, Norway, and Russia.     An event was held today at "Arabkir" BH-ICAH to celebrate this milestone. Distinguished attendees included Minister of Health Anahit Avanesyan, Deputy Minister Armen Gasparyan, Head of the WHO Armenia Office Siddhartha Datta, UN Resident Coordinator Françoise Jacquet, and representatives from UNICEF, UNFPA, the UN World Food Program, and other local and international organizations.     Professor Ara Babloyan, Scientific Director of Arabkir MC-ICAH, welcomed guests, expressing gratitude for their presence on this significant occasion. Reflecting on the institute’s journey since its establishment in 2003, he noted initial skepticism about its purpose. However, the institute's accomplishments have had a profound impact not only in Armenia but also internationally. These efforts, focused on child development, adolescent health, school health, and pediatric care quality, have earned the trust and recognition of the WHO. Arabkir MC-ICAH continues to lead transformative programs in alignment with Armenia's Ministry of Health strategies, contributing to improved health outcomes for children and adolescents.     Sergey Sargsyan, Head of the Institute of Child and Adolescent Health, presented the Institute's activities across various domains, ranging from educational, research, and informational programs to practical medicine. Special emphasis was placed on rehabilitation, newborn screening, rapid response initiatives, and training for nurses and allied health professionals. Notably, one of the most recent achievements is that just a few days ago, the European Council of Pediatrics granted the Arabkir MC-ICAH the status of a pediatric allergology training center meeting European standards.     The attendees were also greeted and congratulated via videoconference by Martin Weber, Head of the Child and Adolescent Health Program at the WHO European Office, who is responsible for quality assurance in medical care.     Siddhartha Datta, Head of the WHO Armenia Office, expressed high appreciation for the work of Arabkir MC-ICAH over the years. He remarked on numerous occasions where he was deeply impressed by the center’s exceptional contributions, which have consistently demonstrated a level of excellence. This outstanding work, he noted, served as the basis for the WHO granting such a prestigious status at the regional level. In his speech, Dr. Datta emphasized the center’s extensive expertise in child and adolescent health, disease prevention, and treatment, as well as its data-driven, research-oriented approaches. He added that such centers of excellence, with their significant achievements and accumulated experience, have the potential to receive recognition as WHO Collaborating Centers, which opens doors for broader collaboration and even greater success.     Minister Anahit Avanesyan, in her speech, described the occasion as historic and of great public and state significance. She stated: "We are proud that this center is the first in Armenia to receive the status of a WHO Collaborating Center. Despite limited resources, our country continuously expands programs aimed at preserving, restoring, and improving the health of children and adolescents. This policy remains a priority."     Upon receiving the document confirming the WHO Collaborating Center status, Ara Babloyan expressed his gratitude, stating: "We are happy to not only learn from the world’s leading health organizations but also share our knowledge and experience with other countries. This is the formula for humanity's progress."